PierianDx

About:

PierianDx is catalyzing global adoption of genomic sequencing in healthcare

Website: https://www.pieriandx.com

Twitter/X: pieriandx

Top Investors: RTI International, ARUP Laboratories, OrbiMed, Health Catalyst, Health Catalyst Capital

Description:

PierianDx is catalyzing global adoption of genomic sequencing in healthcare by empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases. PierianDx’s industry-leading genomic SaaS solutions, CAP and CLIA accredited laboratory, and shared knowledgebase are used by health systems, cancer centers and commercial laboratories worldwide driving the most integrated approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, PierianDx has rapidly become the trusted source of ‘wisdom’ in every advanced genomic report.

Total Funding Amount:

$74M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

St Louis, Missouri, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)pieriandx.com

Founders:

Rakesh Nagarajan

Number of Employees:

51-100

Last Funding Date:

2021-11-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai